New gene delivery system based on oligochitosan and solid lipid nanoparticles: 'In vitro' and 'in vivo' evaluation

European Journal of Pharmaceutical Sciences

Volumn 50, Issue 3-4, 2013, Pages 484-491

  Delgado, Diego ^a   Del Pozo Rodríguez, Ana ^a   Angeles Solinis M ^a   Bartkowiak, Artur ^b   Rodríguez Gascón, Alicia ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b WEST POMERANIAN UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

'In vivo' transfection; Gene therapy; Non viral vector; Oligochitosan; Solid lipid nanoparticles

Indexed keywords

CHITOSAN DERIVATIVE; DNA; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; FEMALE; GENE DELIVERY SYSTEM; GENE THERAPY; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER; LUNG; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; SPLEEN;

'IN VIVO' TRANSFECTION; CH; CHITOSAN; EGFP; GENE THERAPY; GREEN FLUORESCENT PROTEIN; MM; MOLAR MASS; NON-VIRAL VECTOR; OLIGOCH; OLIGOCHITOSAN; ROOM TEMPERATURE; RT; SLN; SOLID LIPID NANOPARTICLE; SOLID LIPID NANOPARTICLES;

ANIMALS; CHITIN; DIGLYCERIDES; DNA; FATTY ACIDS, MONOUNSATURATED; FEMALE; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; LIVER; LUNG; MICE; MICE, NUDE; NANOPARTICLES; PLASMIDS; POLYSORBATES; QUATERNARY AMMONIUM COMPOUNDS; SPLEEN; TRANSFECTION;

EID: 84883734585     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.08.013     Document Type: Article

References (40)

1. A. Agarwal, S. Majumder, H. Agrawal, S. Majumdar, and P.A. Govind Cationized albumin conjugated solid lipid nanoparticles as vectors for brain delivery of an anti-cancer drug Curr. Nanosci. 7 2011 71 80
2. S. Alex, M.R. Rekha, and C.P. Sharma Spermine grafted galactosylated chitosan for improved nanoparticle mediated gene delivery J. Pharm. 410 2011 125 137
3. P. Baldrick The safety of chitosan as a pharmaceutical excipient Regul. Toxicol. Pharmacol. 56 2010 290 299
4. A. Bartkowiak, and D. Hunkeler Alginate-oligochitosan microcapsules: II. Control of mechanical resistance and permeability of the membrane Chem. Mater. 12 2000 206 212
5. A. Bonincontro, M. Falivene, C.L. Mesa, G. Risuleo, and M.R. Peña Dynamics of DNA adsorption on and release from SDS-DDAB cat-anionic vesicles: a multitechnique study Langmuir 24 2008 1973 1978 (Pubitemid 351500957)
6. K.L. Chang, Y. Higuchi, S. Kawakami, F. Yamashita, and M. Hashida Efficient gene transfection by histidine-modified chitosan through enhancement of endosomal escape Bioconjug. Chem. 21 2010 1087 1095
7. N. Csaba, M. Garcia-Fuentes, and M.J. Alonso The performance of nanocarriers for transmucosal drug delivery Expert Opin. Drug Deliv. 3 2006 463 478
8. N. Csaba, M. Garcia-Fuentes, and M.J. Alonso Nanoparticles for nasal vaccination Adv. Drug Deliv. Rev. 61 2009 140 157
9. N. Csaba, M. Köping-Höggård, and M.J. Alonso Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery Int. J. Pharm. 382 2009 205 214
10. N. Csaba, M. Köping-Höggård, E. Fernandez-Megia, R. Novoa-Carballal, R. Riguera, and M.J. Alonso Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transfer J. Biomed. Nanotechnol. 5 2009 162 171
11. M. de la Fuente, N. Csaba, M. Garcia-Fuentes, and M.J. Alonso Nanoparticles as protein and gene carriers to mucosal surfaces Nanomedicine 3 2008 845 857
12. M. de la Fuente, M. Raviña, P. Paolicelli, A. Sánchez, B. Seijo, and M.J. Alonso Chitosan-based nanostructures: a delivery platform for ocular therapeutics Adv. Drug Deliv. Rev. 62 2010 1101 1117
13. A. del Pozo-Rodríguez, D. Delgado, M.A. Solinís, A.R. Gascón, and J.L. Pedraz Solid lipid nanoparticles: formulation factors affecting cell transfection capacity Int. J. Pharm. 339 2007 261 268 (Pubitemid 46977611)
14. A. del Pozo-Rodríguez, S. Pujals, D. Delgado, M.A. Solinís, A.R. Gascón, E. Giralt, and J.L. Pedraz A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors J. Controlled Release 133 2009 52 59
15. A. del Pozo-Rodríguez, M.A. Solinís, A.R. Gascón, and J.L. Pedraz Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy Eur. J. Pharm. Biopharm. 71 2009 181 189
16. A. del Pozo-Rodríguez, D. Delgado, M.A. Solinís, J.L. Pedraz, E. Echevarría, J.M. Rodríguez, and A.R. Gascón Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration Int. J. Pharm. 385 2010 157 162
17. D. Delgado, A. del Pozo-Rodríguez, M.A. Solinís, and A.R. Gascón Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway Eur. J. Pharm. Biopharm. 79 2011 495 502
18. D. Delgado, A.R. Gascón, A. del Pozo-Rodríguez, E. Echevarría, A.P. Ruiz de Garibay, J.M. Rodríguez, and M.A. Solinís Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: in vitro characterization and in vivo transfection after intravenous administration to mice Int. J. Pharm. 425 2012 35 43
19. D. Delgado, A. del Pozo-Rodríguez, M.A. Solinís, M. Avilés-Triqueros, B.H. Weber, E. Fernández, and A.R. Gascón Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis Hum. Gene Ther. 23 2012 345 355
20. N. Duceppe, and M. Tabrizian Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles Biomaterials 30 2009 2625 2631
21. P.K. Dutta, J. Dutta, and V.S. Tripathi Chitin and chitosan: chemistry, properties and applications J. Sci. Ind. Res. 63 2004 20 31 (Pubitemid 38122923)
22. A. Elouahabi, and J.M. Ruysschaert Formation and intracellular trafficking of lipoplexes and polyplexes Mol. Ther. 11 2005 336 347 (Pubitemid 40277310)
23. M. Garcia-Fuentes, and M.J. Alonso Chitosan-based drug nanocarriers: where do we stand? J. Controlled Release 161 2012 496 504
24. O. Germershaus, S. Mao, J. Sitterberg, U. Bakowsky, and T. Kissel Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro J. Controlled Release 125 2008 145 154 (Pubitemid 350299611)
25. Holme, K.K., Hagen, A., Dornish, M., 2000. Influences of chitosans with various molecular weights and degrees of deacetylation on the permeability of human intestinal epithelial cells (CACO-2). In: Muzzarelli, R.A.A.A. (Ed.), Chitosan per os: From Dietary Supplement to Drug Carrier. Gtottammare, Italy, pp. 127-136.
26. C. Jreyssaty, Q. Shi, H. Wang, X. Qiu, F.M. Winnik, X. Zhang, K. Dai, M. Benderdour, and J.C. Fernandes Efficient non viral gene therapy using folate-targeted chitosan-DNA nanoparticles in vitro ISRN Pharm. 2012 2012 369270
27. T. Kurosaki, T. Kitahara, S. Fumoto, K. Nishida, K. Yamamoto, H. Nakagawa, Y. Kodama, N. Higuchi, T. Nakamura, and H. Sasaki Chondroitin sulfate capsule system for efficient and secure gene delivery J. Pharm. Sci. 13 2010 351 361
28. K.W. Leong, H.Q. Mao, V.L. Truong-Le, K. Roy, S.M. Walsh, and J.T. August DNA polycation nanospheres as non-viral gene delivery vehicles J. Controlled Release 53 1998 183 193 (Pubitemid 28218701)
29. S. Mansouri, P. Lavigne, K. Corsi, M. Benderdour, E. Beaumont, and J.C. Fernandes Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy Eur. J. Pharm. Biopharm. 57 2004 1 8 (Pubitemid 38058799)
30. R.S. Mulik, J. Mönkkönen, R.O. Juvonen, K.R. Mahadik, and A.R. Paradkar Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis Int. J. Pharm. 398 2010 190 203
31. H. Nie, S.T. Khew, L.Y. Lee, K.L. Poh, Y.W. Tong, and C.H. Wang Lysine-based peptide-functionalized PLGA foams for controlled DNA delivery J. Controlled Release 138 2009 64 70
32. Y. Ping, C. Liu, Z. Zhang, K.L. Liu, J. Chen, and J. Li Chitosan-graft-(PEI-b-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery Biomaterials 32 2011 8328 8341
33. R.M. Ramesan, and C.P. Sharma Modification of chitosan nanoparticles for improved gene delivery Nanomedicine 7 2012 5 8
34. S.P. Strand, S. Lelu, N.K. Reitan, C. de Lange Davies, P. Artursson, and K.M. Vårum Molecular design of chitosan gene delivery systems with an optimized balance between polyplex stability and polyplex unpacking Biomaterials 31 2010 975 987
35. M. Thanou, J.C. Verhoef, and H.E. Junginger Chitosan and its derivatives as intestinal absorption enhancers Adv. Drug Deliv. Rev. 50 Suppl 1 2001 S91 S101
36. M. Thibault, S. Nimesh, M. Lavertu, and M.D. Buschmann Intracellular trafficking and decondensation kinetics of chitosan-pDNA polyplexes Mol. Ther. 18 2010 1787 1795
37. M. Thibault, M. Astolfi, N. Tran-Khanh, M. Lavertu, V. Darras, A. Merzouki, and M.D. Buschmann Excess polycation mediates efficient chitosan-based gene transfer by promoting lysosomal release of the polyplexes Biomaterials 32 2011 4639 4646
38. K. Turan, and K. Nagata Chitosan-DNA nanoparticles: the effect of cell type and hydrolysis of chitosan on in vitro DNA transfection Pharm. Dev. Technol. 11 2006 503 512 (Pubitemid 44852432)
39. W. Wang, X. Zhao, H. Hu, D. Chen, J. Gu, Y. Deng, and J. Sun Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability Drug Deliv. 17 2010 114 122
40. K. Wong, G. Sun, X. Zhang, H. Dai, Y. Liu, C. He, and K.W. Leong PEI-g-chitosan, a novel gene delivery system with transfection efficiency comparable to polyethylenimine in vitro and after liver administration in vivo Bioconjug. Chem. 17 2006 152 158 (Pubitemid 43157597)